Insights

CRC Treatment Focus CytomX Therapeutics is actively developing the CRC treatment CX-2051, presenting a potential sales opportunity for partnerships, collaborations, or licensing agreements in the oncology space.

Anti-Tumor Combination Therapy Through collaboration with Merck, CytomX Therapeutics is working on developing an anti-tumor combination therapy. This partnership opens doors for potential joint ventures or product integration opportunities with other pharmaceutical companies.

mRNA-Based Therapeutics Development With a focus on mRNA-based therapeutics for oncology and non-oncology conditions, CytomX Therapeutics is at the forefront of innovative treatment methods. This presents a promising avenue for sales of proprietary technologies, intellectual property licensing, or research partnerships.

Chief Financial Officer Promotion The promotion of Chris Ogden to Chief Financial Officer indicates growth and strategic financial management at CytomX Therapeutics. This presents a potential opportunity for financial service providers or consultants to engage with the company.

Diverse Board of Directors Enhancing the Board of Directors with Dr. Zhen Su's appointment signifies a commitment to diverse leadership and expertise. Sales professionals in board advisory services or industry networking could leverage this diversity opportunity for business development.

CytomX Therapeutics Tech Stack

CytomX Therapeutics uses 8 technology products and services including EY, MATLAB, WordPress, and more. Explore CytomX Therapeutics's tech stack below.

  • EY
    Accounting
  • MATLAB
    Advanced Analytics And Data Science
  • WordPress
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Nagios
    IT Infrastructure & Operations Management
  • Adobe Creative Suite
    Visualisation Software
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

CytomX Therapeutics's Email Address Formats

CytomX Therapeutics uses at least 1 format(s):
CytomX Therapeutics Email FormatsExamplePercentage
FLast@cytomx.comJDoe@cytomx.com
91%
FiLast@cytomx.comJoDoe@cytomx.com
5%
First@cytomx.comJohn@cytomx.com
2%
First.Last@cytomx.comJohn.Doe@cytomx.com
2%

Frequently Asked Questions

Where is CytomX Therapeutics's headquarters located?

Minus sign iconPlus sign icon
CytomX Therapeutics's main headquarters is located at 151 Oyster Point Blvd South San Francisco, CA 94080 US. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is CytomX Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact CytomX Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CytomX Therapeutics's stock symbol?

Minus sign iconPlus sign icon
CytomX Therapeutics is a publicly traded company; the company's stock symbol is CTMX.

What is CytomX Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
CytomX Therapeutics's official website is cytomx.com and has social profiles on LinkedIn.

How much revenue does CytomX Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, CytomX Therapeutics's annual revenue reached $35M.

What is CytomX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
CytomX Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CytomX Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, CytomX Therapeutics has approximately 159 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: S. M.Chief Business Officer And Head Of Strategy: J. L.Chief Human Resources Officer: D. O.. Explore CytomX Therapeutics's employee directory with LeadIQ.

What industry does CytomX Therapeutics belong to?

Minus sign iconPlus sign icon
CytomX Therapeutics operates in the Biotechnology Research industry.

What technology does CytomX Therapeutics use?

Minus sign iconPlus sign icon
CytomX Therapeutics's tech stack includes EYMATLABWordPressMySQLFont AwesomeNagiosAdobe Creative SuiteAcquia Cloud Site Factory.

What is CytomX Therapeutics's email format?

Minus sign iconPlus sign icon
CytomX Therapeutics's email format typically follows the pattern of . Find more CytomX Therapeutics email formats with LeadIQ.

How much funding has CytomX Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, CytomX Therapeutics has raised $94M in funding. The last funding round occurred on Jan 21, 2021 for $94M.
CytomX Therapeutics

CytomX Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. 

Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. 

CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected.

We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population.

CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category.

CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.

Section iconCompany Overview

Headquarters
151 Oyster Point Blvd South San Francisco, CA 94080 US
Phone number
Website
cytomx.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CTMX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $94M

    CytomX Therapeutics has raised a total of $94M of funding over 8 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $94M.

  • $10M$50M

    CytomX Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $94M

    CytomX Therapeutics has raised a total of $94M of funding over 8 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $94M.

  • $10M$50M

    CytomX Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.